c-Met signalling: Spatio-temporal decisions

Cell Cycle

Volumn 4, Issue 3, 2005, Pages 352-355

  Kermorgant, S ^a   Parker, P J ^a,b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b THE FRANCIS CRICK INSTITUTE   (United Kingdom)

Author keywords

c Met; Cell migration; Endosome; ERK1 2; Focal complexes; Integrin; PKC; Signals dynamics; Traffic

Indexed keywords

CYTOSKELETON PROTEIN; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PAXILLIN; PROTEIN TYROSINE KINASE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

CANCER; CELL ADHESION; CELL DIFFERENTIATION; CELL MEMBRANE; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; CELL SPREADING; CELL STRUCTURE; ENDOCYTOSIS; ENDOSOME; ENZYME ACTIVATION; ENZYME LOCALIZATION; GENE OVEREXPRESSION; GENE TRANSLOCATION; GERM LINE; HUMAN; INTERNALIZATION; NONHUMAN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SOMATIC MUTATION; STEADY STATE; TRANSCRIPTION INITIATION; UBIQUITINATION;

EID: 25444461165     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.4.3.1519     Document Type: Review

References (33)

1. Comoglio PM, Trusolino L. Invasive growth: From development to metastasis. J Clin Invest 2002; 109:857-62.
2. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003; 4:915-25.
3. Ma PC, Maulik G, Christensen J, Salgia R. c-Met: Structure, functions and potential for therapeutic inhibition. Cancer Metastasis Rev 2003; 22:309-25.
4. Jeffers M, Taylor GA, Weidner KM, Omura S, Vande Woude GF. Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway. Mol Cell Biol 1997; 17:799-808.
5. Peschard P, Fournier TM, Lamorte L, Naujokas MA, Band H, Langdon WY, Park M. Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein. Mol Cell 2001; 8:995-1004.
6. Hammond DE, Urbe S, Vande Woude GF, Clague MJ. Downregulation of MET, the receptor for hepatocyte growth factor. Oncogene 2001; 20:2701-70.
7. Kermorgant S, Zicha D, Parker PJ. Protein kinase C controls microtubule-based traffic but not proteasomal degradation of c-Met. J Biol Chem 2003; 278:28921-9.
8. Petrelli A, Gilestro GF, Lanzardo S, Comoglio PM, Migone N, Giordano S. The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met. Nature 2002; 416:187-90.
9. Oved S, Yarden Y. Signal transduction: Molecular ticket to enter cells. Nature 2002; 416:133-6.
10. Kamei T, Matozaki T, Sakisaka T, Kodama A, Yokoyama S, Peng YF, Nakano K, Takaishi K, Takai Y. Coendocytosis of cadherin and c-Met coupled to disruption of cell-cell adhesion in MDCK cells - regulation by Rho, Rac and Rab small G proteins. Oncogene 1999; 18:6776-84.
11. Hammond DE, Carter S, McCullough J, Urbe S, Vande Woude G, Clague MJ. Endosomal dynamics of Met determine signaling output. Mol Biol Cell 2003; 14:1346-54.
12. Carter S, Urbe S, Clague MJ. The met receptor degradation pathway: Requirement for K48-linked polyubiquitin independent of proteasome activity. J Biol Chem 2004.
13. Kermorgant S, Zicha D, Parker PJ. PKC controls HGF-dependent c-Met traffic, signalling and cell migration. Embo J 2004; 23:3721-34.
14. Ishibe S, Joly D, Zhu X, Cantley LG. Phosphorylation-dependent paxillin-ERK association mediates hepatocyte growth factor-stimulated epithelial morphogenesis. Mol Cell 2003; 12:1275-85.
15. Potempa S, Ridley AJ. Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly. Mol Biol Cell 1998; 9:2185-200.
16. Di Guglielmo GM, Baass PC, Ou WJ, Posner BI, Bergeron JJ. Compartmentalization of SHC, GRB2 and mSOS, and hyperphosphorylation of Raf-1 by EGF but not insulin in liver parenchyma. Embo J 1994; 13:4269-77.
17. Jiang X, Sorkin A. Coordinated traffic of Grb2 and Ras during epidermal growth factor receptor endocytosis visualized in living cells. Mol Biol Cell 2002; 13:1522-35.
18. Burke P, Schooler K, Wiley HS. Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking. Mol Biol Cell 2001; 12:1897-910.
19. McPherson PS, Kay BK, Hussain NK. Signaling on the endocytic pathway. Traffic 2001; 2:375-84.
20. Vieira AV, Lamaze C, Schmid SL. Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 1996; 274:2086-9.
21. Ceresa BP, Kao AW, Santeler SR, Pessin JE. Inhibition of clathrin-mediated endocytosis selectively attenuates specific insulin receptor signal transduction pathways. Mol Cell Biol 1998; 18:3862-70.
22. Garrington TP, Johnson GL. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol 1999; 11:211-8.
23. Teis D, Huber LA. The odd couple: Signal transduction and endocytosis. Cell Mol Life Sci 2003; 60:2020-33.
24. Davis RJ. Transcriptional regulation by MAP kinases. Mol Reprod Dev 1995; 42:459-67.
25. Carragher NO, Frame MC. Focal adhesion and actin dynamis: a place where kinases and proteases meet to promote invasion. Trends in Cell Biology 2004; 14:241-9.
26. Roberts MS, Woods AJ, Shaw PE, Norman JC. ERK1 associates with alpha(v)beta 3 integrin and regulates cell spreading on vitronectin. J Biol Chem 2003; 278:1975-85.
27. Anand-Apte B, Zetter B. Signaling mechanisms in growth factor-stimulated cell motility. Stem Cells 1997; 15:259-67.
28. Woods AJ, White DP, Caswell PT, Norman JC. PKD1/PKCmicro promotes alphavbeta3 integrin recycling and delivery to nascent focal adhesions. Embo J 2004; 23:2531-43.
29. Ivaska J, Whelan RD, Watson R, Parker PJ. PKCepsilon controls the traffic of beta1 integrins in motile cells. Embo J 2002; 21:3608-19.
30. Ishibe S, Joly D, Liu ZX, Cantley LG. Paxillin serves as an ERK-regulated scaffold for coordinating FAK and Rac activation in epithelial morphogenesis. Mol Cell 2004; 16:257-67.
31. Osawa M, Itoh S, Ohta S, Huang Q, Berk BC, Marmarosh NL, Che W, Ding B, Yan C, Abe J. ERK1/2 associates with the c-Met-binding domain of growth factor receptor-bound protein 2 (Grb2)-associated binder-1 (Gab1): Role in ERK1/2 and early growth response factor-1 (Egr-1) nuclear accumulation. J Biol Chem 2004; 279:29691-9.
32. Besson A, Davy A, Robbins SM, Yong VW. Differential activation of ERKs to focal adhesions by PKC epsilon is required for PMA-induced adhesion and migration of human glioma cells. Oncogene 2001; 20:7398-407.
33. Traverse S, Seedorf K, Paterson H, Marshall CJ, Cohen P, Ullrich A. EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr Biol 1994; 4:694-701.